Targeted therapeutic delivery of vitamin D compounds
First Claim
1. A conjugate comprising at least one vitamin D moiety associated with a target molecule moiety having an affinity for a tissue of interest.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention is directed to a conjugate which includes at least one vitamin D moiet thereof and at least one targeting molecule moiety to pharmaceutical compositions of the conjugate. and to methods for using the conjugate for target- specific delivery of vitamin D or analogs thereof to tissues in need thereof. When a particularly preferred form is administered to a patient, the targeting molecule component of the conjugate of this invention seeks out and binds to a tissue of interest, such as bone or tuinor tissue, where the vitamin D has a therapeutic effect.
-
Citations
40 Claims
- 1. A conjugate comprising at least one vitamin D moiety associated with a target molecule moiety having an affinity for a tissue of interest.
-
20. A pharmaceutical composition comprising:
a conjugate which includes at least one vitamin D moiety associated with at least one target molecule moiety having an affinity for a tissue of interest, and a suitable pharmaceutically acceptable carrier. - View Dependent Claims (21, 22, 24, 25, 26, 27, 29, 30, 31)
-
23. A method of site-specific delivery of a vitamin D moiety to a tissue of interest in a patient, comprising the steps of:
-
a. providing a conjugate which includes a vitamin D moiety in a pharmaceutically acceptable carrier, the conjugate having at least one vitamin D moiety associated with at least one target molecule moiety, the target molecule moiety having an affinity for the tissue of interest, and b. administering a therapeutically effective dose of the conjugate to the patient.
-
-
28. A conjugate of formula (1)
(D)m* (T)n -
(1)wherein each D represents a vitamin D moiety;
each T represents a target molecule moiety;
n and m represent integers of 1 or greater; and
* indicates that the target molecule moiety is associated with the vitamin D moiety.
-
-
32. A conjugate of formula (IV)
[(T)n-(G′ - )f]g* [(G″
)n- (D)m]r
(IV)wherein each G′
represents a connecting group;
each G″
represents the same or different connecting group as G′
;
each D represents a vitamin D moiety;
each T represents a target molecule moiety;
g, k, n and m represent integers of 1 or greater; and
f and h represent integers of 0 or greater;
—
indicates a bond in instances where a connecting group is present; and
* indicates that each D is associated with each T via connector G′
or G″
or via connector G′
and G″
when both connectors are present.- View Dependent Claims (33, 35, 36, 37, 38, 39, 40)
- )f]g* [(G″
-
34. The conjugate of formula (XV):
-
(D)m*(T)n(A)p
(XV)wherein each D represents a vitamin D moiety;
each T represents a target molecule moiety;
each A represents a therapeutic agent other than vitamin D;
m, n and p represent integers of 1 or greater; and
* indicates that the target molecule moiety is associated with the vitamin D moiety and with the therapeutic agent other than vitamin D.
-
Specification